In-Q-Tel Backs Quanterix to Expand Pathogen Detection for Defense Applications
January 10, 2012
In-Q-Tel Backs Quanterix to Expand Pathogen Detection for Defense Applications
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- BioMerieux Invests $15M in Quanterix, Will Use SiMoA to Support PSA and Infectious Disease Assays
November 27, 2012 / BioArray News - Following Management Changes, Nanosphere Reports Revenue Growth, but Shortfalls in Dx Placements
February 26, 2013 / BioArray News - Quanterix Building Commercial Team Ahead of Planned 2013 Launch for Simoa Platform
July 24, 2012 / BioArray News - With Backing from In-Q-Tel, Quanterix Continues Move into Pathogen Detection, Defense Applications
January 6, 2012 / ProteoMonitor - Quanterix's AccuPSA Test Predicts Five-Year Recurrence-Free Survival in Prostate Cancer Study
October 21, 2011 / ProteoMonitor